September 2021 Press Releases Convergent Therapeutics and Point Biopharma Announce a Collaboration to Evaluate CONV01-α (Rosopatamab-225Ac) in combination with PNT2002 for Progressive Metastatic Castration-Resistant Prostate Cancer
August 2021 Press Releases Convergent Therapeutics Appoints Alexander Brown as Chief Operating Officer
July 2021 Press Releases Convergent Therapeutics Appoints Philip Kantoff, M.D. as Chief Executive Officer
